These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21998342)

  • 1. Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.
    Wilson DH; Hanlon DW; Provuncher GK; Chang L; Song L; Patel PP; Ferrell EP; Lepor H; Partin AW; Chan DW; Sokoll LJ; Cheli CD; Thiel RP; Fournier DR; Duffy DC
    Clin Chem; 2011 Dec; 57(12):1712-21. PubMed ID: 21998342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study.
    Lepor H; Cheli CD; Thiel RP; Taneja SS; Laze J; Chan DW; Sokoll LJ; Mangold L; Partin AW
    BJU Int; 2012 Jun; 109(12):1770-5. PubMed ID: 21992499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of a Fifth-Generation Ultrasensitive Prostate-Specific Antigen Assay for Monitoring Prostate Cancer Patients after Radical Prostatectomy with 3 Years of Follow-Up.
    Ren AH; Soosaipillai A; Mathew A; Nikolenko G; Sardesai L; Stengelin M; Diamandis EP
    Clin Chem; 2020 Oct; 66(10):1329-1338. PubMed ID: 33001184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology.
    McDermed JE; Sanders R; Fait S; Klem RE; Sarno MJ; Adams TH; Diamandis EP
    Clin Chem; 2012 Apr; 58(4):732-40. PubMed ID: 22361936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.
    Stamey TA; Graves HC; Wehner N; Ferrari M; Freiha FS
    J Urol; 1993 Apr; 149(4):787-92. PubMed ID: 7681119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range.
    Rissin DM; Fournier DR; Piech T; Kan CW; Campbell TG; Song L; Chang L; Rivnak AJ; Patel PP; Provuncher GK; Ferrell EP; Howes SC; Pink BA; Minnehan KA; Wilson DH; Duffy DC
    Anal Chem; 2011 Mar; 83(6):2279-85. PubMed ID: 21344864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.
    Malik RD; Goldberg JD; Hochman T; Lepor H
    Eur Urol; 2011 Sep; 60(3):548-53. PubMed ID: 21652145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
    Shen S; Lepor H; Yaffee R; Taneja SS
    J Urol; 2005 Mar; 173(3):777-80. PubMed ID: 15711268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
    Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P
    Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation PSA: ultrasensitive or ultraprecise assay?
    Mione R; Barichello M; Sartorello P; Leon A; Barioli P; Gion M
    Int J Biol Markers; 1995; 10(4):229-33. PubMed ID: 8750651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy.
    Hong SK; Park HZ; Lee WK; Kim DS; Lee JS; Doo SH; Jeong SJ; Yoon CY; Byun SS; Lee SE
    Urology; 2010 Sep; 76(3):723-7. PubMed ID: 20579699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
    van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
    Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up.
    Vassilikos EJ; Yu H; Trachtenberg J; Nam RK; Narod SA; Bromberg IL; Diamandis EP
    Clin Biochem; 2000 Mar; 33(2):115-23. PubMed ID: 10751589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
    Haese A; Huland E; Graefen M; Hammerer P; Noldus J; Huland H
    J Urol; 1999 Apr; 161(4):1206-11. PubMed ID: 10081870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.
    Wiegel T; Bartkowiak D; Bottke D; Thamm R; Hinke A; Stöckle M; Rübe C; Semjonow A; Wirth M; Störkel S; Golz R; Engenhart-Cabillic R; Hofmann R; Feldmann HJ; Kälble T; Siegmann A; Hinkelbein W; Steiner U; Miller K
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):288-94. PubMed ID: 25445556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.
    Ellis WJ; Vessella RL; Noteboom JL; Lange PH; Wolfert RL; Rittenhouse HG
    Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen.
    Freedland SJ; Terris MK; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Aronson WJ;
    J Urol; 2004 Jun; 171(6 Pt 1):2215-20. PubMed ID: 15126788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy.
    Witherspoon LR; Lapeyrolerie T
    J Urol; 1997 Apr; 157(4):1322-8. PubMed ID: 9120931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations.
    Rissin DM; Kan CW; Campbell TG; Howes SC; Fournier DR; Song L; Piech T; Patel PP; Chang L; Rivnak AJ; Ferrell EP; Randall JD; Provuncher GK; Walt DR; Duffy DC
    Nat Biotechnol; 2010 Jun; 28(6):595-9. PubMed ID: 20495550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief review of ultrasensitive prostate-specific antigen assays for the evaluation of patients after radical prostatectomy.
    Takayama TK; Vessella RL; Lange PH
    World J Urol; 1993; 11(4):192-5. PubMed ID: 7508782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.